Sponsor pipeline

McGill University Health Centre/Research Institute of the McGill University Health Centre clinical trial pipeline

Get alerts when McGill University Health Centre/Research Institute of the McGill University Health Centre's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

5 trials changed in the last 30 days: 1 stopped, 2 with notable changes, 2 with minor changes only.

  1. Stopped

    AFS_T1D · Artificial Sweetener (AFS) on Glucose Metabolism · Type 1 Diabetes (T1D)

    Trial terminated

    Sponsor's reason: The study was terminated due to recruitment difficulties. Only three participants enrolled within two years due to specific insulin pump requirements. Recruitment was therefore discontinued before the planned sample size was reached.

    Also in this update: Primary completion date changed from estimate of Nov 1, 2025 to Sep 22, 2026; Final enrollment: 3 participants (planned 25)

    McGill University Health Centre/Research Institute of the McGill University Health CentreNot specified NCT06315725 Registry history of NCT06315725 on ClinicalTrials.gov (opens the registry)

    Updated

Show 2 trials with minor changes only
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-13 NCT07871838 Safety, Efficacy and Quality of Life After Adjuvant Hypofractionated Radiotherapy for… Recruiting
2026-09-30 NCT07850648 The CANadian EXAcerbation of COPD Trial Not Yet Recruiting
2026-09-29 NCT07848204 Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors Phase 1 Completed

Active trials by phase

Early Phase 1
1
Phase 1
2
Phase 2
8
Phase 2/3
4
Phase 3
2
Phase 4
9
Not charted: 72 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 98

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06650501 Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia Staphylococcus Aureus Endocarditis Recruiting 2026-09-24
NCT07374952 Minimal Effective Volume 90% for Double-injection Costoclavicular Block Brachial Plexus Blocks Recruiting 2026-07-07
NCT07556952 Dex & Mastectomy Pain Post-Mastectomy Chronic Pain Syndrome Recruiting 2026-06-04
NCT07303686 De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative… Crohn Disease (CD) Recruiting 2025-12-26
NCT06613178 Intravenous Acetaminophen After Cardiac Surgery - Definitive Study Post Operative Delirium Recruiting 2024-09-25
NCT07732452 Hormone thERapy Effects on BRAin-HEART Health During the Menopausal Transition Menopause Not Yet Recruiting 2026-07-29
NCT07357103 Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) Pneumocystis Not Yet Recruiting 2026-01-21
NCT07328984 How Long Should we Give Steroids for Patients With Severe PCP Pneumocystis Pneumonia Not Yet Recruiting 2026-01-09
NCT06375304 The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study HIV Infections Not Yet Recruiting 2024-04-19
Phase 3
NCT07328971 Vancomycin Taper to Prevent Recurrent Clostridioides Difficile Clostridia Difficile Colitis Recruiting 2026-09-23
NCT06894784 A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to… Diabetes Type 1 Recruiting 2025-03-30
Phase 2/3
NCT06979609 Secondary Prevention of Clostridioides Difficile Using Vancomycin Clostridioides Difficile Infection Recruiting 2026-06-24
NCT07284511 A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically… Type 1 Diabetes Recruiting 2026-05-27
NCT06498414 Shorter and Safer Treatment Regimens for Latent TB Tuberculosis Infection, Latent Recruiting 2026-05-11
NCT06387199 Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop… Type 1 Diabetes Recruiting 2024-12-18
Phase 2
NCT06913647 Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis ESRD Recruiting 2026-03-16
NCT06599658 COVID-19 Booster and IIV Schedule in Immunocompromised Hosts COVID 19 Recruiting 2026-03-10
NCT06182839 Canagliflozin in Advanced Renal Disease With MRI Endpoints ESRD, CKD Stage 4, CKD Stage 5 Recruiting 2025-12-08
NCT04249154 Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer Prostate Cancer Recruiting 2025-06-25
NCT07625930 RESTAGE (REpurposing STAtins to Improve Outcomes in GastroEsophageal Cancer) Trial Gastroesophageal Adenocarcinoma Not Yet Recruiting 2026-07-10
NCT07439406 Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy Peanut Allergy Not Yet Recruiting 2026-03-03
NCT02780024 Metformin, Neo-adjuvant Temozolomide and Hypo- Accelerated Radiotherapy Followed by… Glioblastoma Multiforme Active, Not Recruiting 2025-06-26
NCT05258422 Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT) Ventricular Tachycardia Enrolling by Invitation 2025-03-18
Phase 1
NCT07069582 Pharmacokinetics of Antituberculosis Drugs in Breastfeeding Women Tuberculosis Infection Not Yet Recruiting 2026-02-10
NCT06299176 Whole Heart Radiotherapy for End-stage Heart Failure Heart Failure NYHA Class III Enrolling by Invitation 2025-05-14

Disease areas by active trials, top 10 of 23

Get alerts when McGill University Health Centre/Research Institute of the McGill University Health Centre's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free